Table 2. Results of Logistic Regression Analyses.
Covariate | Answered yes to the following question, OR (95% CI)a | |||||
---|---|---|---|---|---|---|
Have you ever heard about HPV? | Have you ever received at least 1 HPV vaccine dose? | Would you wish to be informed about HPV at your GP’s office, independently of whether you are vaccinated against HPV? | ||||
Crude | Adjusted | Crude | Adjusted | Crude | Adjusted | |
Female gender | 1.91 (1.70-2.15) | 1.89 (1.67-2.14) | 5.01 (4.31-5.84) | 4.74 (4.07-5.53) | 0.97 (0.77-1.22) | 0.99 (0.78-1.24) |
Age (reference: <20 y) | ||||||
20-25 y | 1.86 (1.57-2.22) | 2.25 (1.86-2.71) | 1.21 (1.01-1.45) | 1.55 (1.27-1.88) | 1.15 (0.82-1.58) | 1.17 (0.84-1.63) |
≥ 26 y | 3.17 (2.58-3.92) | 3.87 (3.08-4.87) | 0.93 (0.76-1.15) | 1.29 (1.02-1.63) | 1.01 (0.69-1.45) | 0.97 (0.65-1.43) |
Enrolled in health care–related program | 2.11 (1.85-2.41) | 2.30 (2.00-2.65) | 2.33 (2.07-2.62) | 2.08 (1.83-2.37) | 1.01 (0.81-1.27) | 1.05 (0.83-1.33) |
Health insurance model (reference: managed care models) | ||||||
Standard model | 1.31 (1.13-1.53) | 1.27 (1.08-1.49) | 1.40 (1.22-1.61) | 1.35 (1.16-1.56) | 0.89 (0.69-1.18) | 0.87 (0.67-1.14) |
Unknown | 0.67 (0.58-0.77) | 0.81 (0.69-0.95) | 0.92 (0.79-1.07) | 0.95 (0.81-1.13) | 1.02 (0.77-1.37) | 0.99 (0.74-1.34) |
Mainly lived outside Switzerland at age 11-18 y | 1.49 (1.20-1.85) | 1.64 (1.30-2.05) | 0.68 (0.55-0.83) | 0.90 (0.72-1.13) | 1.65 (1.06- 2.74) | 1.75 (1.08-2.83) |
Abbreviations: GP, general practitioner; HPV, human papillomavirus; OR, odds ratio.
Results are reported in terms of crude and adjusted ORs with 95% CIs. The denominator population corresponds to all included respondents except those who indicated gender as other, since their rare occurrence would have led to high statistical imbalance (n = 5496; 99.5% of total).